Redox Signaling Mediated by Thioredoxin and Glutathione Systems in the Central Nervous System

Antioxidants and Redox Signaling

Volumn 27, Issue 13, 2017, Pages 989-1010

  Ren, Xiaoyuan ^a   Zou, Lili ^a,b   Zhang, Xu ^a   Branco, Vasco ^c   Wang, Jun ^b   Carvalho, Cristina ^c   Holmgren, Arne ^a   Lu, Jun ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b CHINA THREE GORGES UNIVERSITY   (China)

^c RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^d SOUTHWEST UNIVERSITY   (China)

Author keywords

CNS; Glutaredoxin; Glutathione; Redox signaling; Thiol targeted compounds; Thioredoxin

Indexed keywords

GLUTATHIONE; HYDROGEN PEROXIDE; MERCURY; MITOCHONDRIAL PROTEIN; PARAQUAT; PROTEIN S; PROTEIN TYROSINE KINASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SELENIUM; THIOREDOXIN; UBIQUINONE;

APOPTOSIS; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; ENDOPLASMIC RETICULUM STRESS; HUMAN; NITROSYLATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATION REDUCTION STATE; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MODIFICATION; REGULATORY MECHANISM; REPERFUSION INJURY; REVIEW; S DESULFHYDRATION; S GLUTATHIONYLATION; SIGNAL TRANSDUCTION; METABOLISM;

CENTRAL NERVOUS SYSTEM; GLUTATHIONE; HUMANS; OXIDATION-REDUCTION; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; THIOREDOXINS;

EID: 85030224041     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2016.6925     Document Type: Review

References (224)

1. Aberg F, Appelkvist EL, Dallner G, and Ernster L. Distribution and redox state of ubiquinones in rat and human tissues. Arch Biochem Biophys 295: 230-234, 1992.
2. Akterin S, Cowburn RF, Miranda-Vizuete A, Jimenez A, Bogdanovic N, WinbladB, and Cedazo-Minguez A. Involvement of glutaredoxin-1 and thioredoxin-1 in betaamyloid toxicity and Alzheimer's disease. Cell Death Differ 13: 1454-1465, 2006.
3. Alehagen U and Aaseth J. Selenium and coenzyme Q10 interrelationship in cardiovascular diseases-a clinician's point of view. J Trace Elem Med Biol 31: 157-162, 2015.
4. Alehagen U, Johansson P, Bjornstedt M, Rosen A, and Dahlstrom U. Cardiovascular mortality and N-terminalproBNP reduced after combined selenium and coenzyme Q10 supplementation: a 5-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens. Int J Cardiol 167: 1860-1866, 2013.
5. Anand P and Stamler JS. Enzymatic mechanisms regulating protein S-nitrosylation: implications in health and disease. J Mol Med (Berl) 90: 233-244, 2012.
6. Andreyev AY, Kushnareva YE, Murphy AN, and Starkov AA. Mitochondrial ROS metabolism: 10 years later. Biochemistry 80: 517-531, 2015.
7. Aon-Bertolino ML, Romero JI, Galeano P, Holubiec M, Badorrey MS, Saraceno GE, Hanschmann EM, Lillig CH, and Capani F. Thioredoxin and glutaredoxin system proteins-immunolocalization in the rat central nervous system. Biochim Biophys Acta 1810: 93-110, 2011.
8. Aoyama K and Nakaki T. Inhibition of GTRAP3-18 may increase neuroprotective glutathione (GSH) synthesis. Int J Mol Sci 13: 12017-12035, 2012.
9. Aoyama K, Watabe M, and Nakaki T. Regulation of neuronal glutathione synthesis. J Pharmacol Sci 108: 227-238, 2008.
10. Arodin L, Lamparter H,KarlssonH,Nennesmo I, Bjornstedt M, Schroder J, and Fernandes AP. Alteration of thioredoxin and glutaredoxin in the progression of Alzheimer's disease. J Alzheimers Dis 39: 787-797, 2014.
11. Augustyniak A, Michalak K, and Skrzydlewska E. [The action of oxidative stress induced by ethanol on the central nervous system (CNS)]. Postepy Hig Med Dosw (Online) 59: 464-471, 2005.
12. Awadalla EA. Efficacy of vitamin C against liver and kidney damage induced by paraquat toxicity. Exp Toxicol Pathol 64: 431-434, 2012.
13. Barrett DM, Black SM, Todor H, Schmidt-Ullrich RK, Dawson KS, and Mikkelsen RB. Inhibition of proteintyrosine phosphatases by mild oxidative stresses is dependent on S-nitrosylation. J Biol Chem 280: 14453-14461, 2005.
14. Barrett WC, DeGnore JP, Konig S, Fales HM, Keng YF, Zhang ZY, Yim MB, and Chock PB. Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry 38: 6699-6705, 1999.
15. Bartlett RM, Holden JE, Nickles RJ, Murali D, Barbee DL, Barnhart TE, Christian BT, and DeJesus OT. Paraquat is excluded by the blood brain barrier in rhesus macaque: an in vivo pet study. Brain Res 1259: 74-79, 2009.
16. Bartlett RM, Murali D, Nickles RJ, Barnhart TE, Holden JE, and DeJesus OT. Assessment of fetal brain uptake of paraquat in utero using in vivo PET/CT imaging. Toxicol Sci 122: 551-556, 2011.
17. Bazinet RP and Laye S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci 15: 771-785, 2014.
18. Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, Griebner B, Watts A, Gao S, Pourcher E, Bond L, Kompoliti K, Agarwal P, Sia C, Jog M, Cole L, Sultana M, Kurlan R, Richard I, Deeley C, Waters CH, Figueroa A, Arkun A, Brodsky M, Ondo WG, Hunter CB, Jimenez-Shahed J, Palao A, Miyasaki JM, Julie SO, Tetrud J, Reys L, Smith K, Singer C, Blenke A, Russell DS, Cotto C, Friedman JH, Lannon M, Zhang L, Drasby E, Kumar R, Subramanian T, Ford DS, Grimes DA, Cote D, Conway J, Siderowf AD, Evatt ML, Sommerfeld B, Lieberman AN, Okun MS, Rodriguez RL, Merritt S, Swartz CL, Martin WRW, King P, Stover N, Guthrie S, Watts RL, Ahmed A, Fernandez HH, Winters A, Mari Z, Dawson TM, Dunlop B, Feigin AS, Shannon B, Nirenberg MJ, Ogg M, Ellias SA, Thomas CA, Frei K, Bodis-Wollner I, Glazman S, Mayer T, Hauser RA, Pahwa R, Langhammer A, Ranawaya R, Derwent L, Sethi KD, Farrow B, Prakash R, Litvan I, Robinson A, Sahay A, Gartner M, Hinson VK, Markind S, Pelikan M, Perlmutter JS, Hartlein J, Molho E, Evans S, Adler CH, Duffy A, Lind M, Elmer L, Davis K, Spears J, Wilson S, Leehey MA, Hermanowicz N, Niswonger S, Shill HA, Obradov S, Rajput A, Cowper M, Lessig S, Song D, Fontaine D, Zadikoff C, Williams K, Blindauer KA, Bergholte J, Propsom CS, Stacy MA, Field J, Mihaila D, Chilton M, Uc EY, Sieren J, Simon DK, Kraics L, Silver A, Boyd JT, Hamill RW, Ingvoldstad C, Young J, Thomas K, Kostyk SK, Wojcieszek J, Pfeiffer RF, Panisset M, Beland M, Reich SG, Cines M, Zappala N, Rivest J, Zweig R, Lumina LP, Hilliard CL, Grill S, Kellermann M, Tuite P, Rolandelli S, Kang UJ, Young J, Rao J, Cook MM, Severt L, and Boyar K. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease no evidence of benefit. JAMA Neurol 71: 543-552, 2014.
19. Beer SM, Taylor ER, Brown SE, Dahm CC, Costa NJ, RunswickMJ, andMurphyMP.Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins-implications for mitochondrial redox regulation and antioxidant defense. J Biol Chem 279: 47939-47951, 2004
20. Behne D, Pfeifer H, Rothlein D, and Kyriakopoulos A. Cellular and subcellular distribution of selenium and selenium-containing proteins in the rat. Trace Elem Man Anim 10: 29-34, 2000.
21. Benhar M, Forrester MT, Hess DT, and Stamler JS. Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins. Science 320: 1050-1054, 2008.
22. Benhar M, Forrester MT, and Stamler JS. Protein denitrosylation: enzymatic mechanisms and cellular functions. Nat Rev Mol Cell Biol 10: 721-732, 2009.
23. Benhar M, Thompson JW, Moseley MA, and Stamler JS. Identification of S-nitrosylated targets of thioredoxin using a quantitative proteomic approach. Biochemistry 49: 6963-6969, 2010.
24. Bilan DS and Belousov VV. HyPer family probes: state of the art. Antioxid Redox Signal 24: 731-751, 2016.
25. Blanco-Ayala T, Anderica-Romero AC, and Pedraza-Chaverri J. New insights into antioxidant strategies against paraquat toxicity. Free Radic Res 48: 623-640, 2014.
26. Bogdan C. Nitric oxide and the immune response. Nat Immunol 2: 907-916, 2001.
27. Branco V, Canario J, Holmgren A, and Carvalho C. Inhibition of the thioredoxin system in the brain and liver of zebra-seabreams exposed to waterborne methylmercury. Toxicol Appl Pharmacol 251: 95-103, 2011.
28. Branco V, Canario J, Lu J, Holmgren A, and Carvalho C. Mercury and selenium interaction in vivo: effects on thioredoxin reductase and glutathione peroxidase. Free Radic Biol Med 52: 781-793, 2012.
29. Branco V, Godinho-Santos A, Goncalves J, Lu J, Holmgren A, and Carvalho C. Mitochondrial thioredoxin reductase inhibition, selenium status, and Nrf-2 activation are determinant factors modulating the toxicity of mercury compounds. Free Radic Biol Med 73: 95-105, 2014.
30. Brooks AI, Chadwick CA, Gelbard HA, Cory-Slechta DA, and Federoff HJ. Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss. Brain Res 823: 1-10, 1999.
31. Bulato C, Bosello V, Ursini F, and Maiorino M. Effect of mercury on selenium utilization and selenoperoxidase activity in LNCaP cells. Free Radic Biol Med 42: 118-123, 2007.
32. Burbacher TM, Shen DD, Liberato N, Grant KS, Cernichiari E, and Clarkson T. Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal. Environ Health Perspect 113: 1015-1021, 2005.
33. Cao J, Schulte J, Knight A, Leslie NR, Zagozdzon A, Bronson R, Manevich Y, Beeson C, and Neumann CA. Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity. EMBO J 28: 1505-1517, 2009.
34. Carvalho CML, Chew EH, Hashemy SI, Lu J, and Holmgren A. Inhibition of the human thioredoxin system-a molecular mechanism of mercury toxicity. J Biol Chem 283: 11913-11923, 2008.
35. Carvalho CML, Lu J, Zhang X, Arner ESJ, and Holmgren A. Effects of selenite and chelating agents on mammalian thioredoxin reductase inhibited by mercury: implications for treatment of mercury poisoning. FASEB J 25: 370-381, 2011.
36. Castello PR, Drechsel DA, and Patel M. Mitochondria are a major source of paraquat-induced reactive oxygen species production in the brain. J Biol Chem 282: 14186-14193, 2007.
37. Cho DH, Nakamura T, Fang J, Cieplak P, Godzik A, Gu Z, and Lipton SA. S-nitrosylation of Drp1 mediates betaamyloid-related mitochondrial fission and neuronal injury. Science 324: 102-105, 2009.
38. Choi MH, Lee IK, Kim GW, Kim BU, Han YH, Yu DY, Park HS, Kim KY, Lee JS, Choi C, Bae YS, Lee BI, Rhee SG, and Kang SW. Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature 435: 347-353, 2005.
39. Clarkson TW and Magos L. The toxicology of mercury and its chemical compounds. Crit Rev Toxicol 36: 609-662, 2006.
40. Clarkson TW, Magos L, and Myers GJ. Human exposure to mercury: the three modern dilemmas. J Trace Elem Exp Med 16: 321-343, 2003.
41. Clementi E, Brown GC, Feelisch M, and Moncada S. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci U S A 95: 7631-7636, 1998.
42. Conrad M, Sandin A, Forster H, Seiler A, Frijhoff J, Dagnell M, Bornkamm GW, Radmark O, van Huijsduijnen RH, Aspenstrom P, Bohmer F, and Ostman A. 12/15-lipoxygenase-derived lipid peroxides control receptor tyrosine kinase signaling through oxidation of protein tyrosine phosphatases. Proc Natl Acad Sci U S A 107: 15774-15779, 2010.
43. Cooper AJ and Kristal BS. Multiple roles of glutathione in the central nervous system. Biol Chem 378: 793-802, 1997.
44. Cox AG, Winterbourn CC, and Hampton MB. Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling. Biochem J 425: 313-325, 2010.
45. Dagnell M, Frijhoff J, Pader I, Augsten M, Boivin B, Xu J, Mandal PK, Tonks NK, Hellberg C, Conrad M, Arner ES, and Ostman A. Selective activation of oxidized PTP1B by the thioredoxin system modulates PDGF-beta receptor tyrosine kinase signaling. Proc Natl Acad Sci U S A 110: 13398-13403, 2013.
46. DelaTorre A, Schroeder RA, and Kuo PC. Alteration of NF-kappa B p50 DNA binding kinetics by S-nitrosylation. Biochem Biophys Res Commun 238: 703-706, 1997.
47. Deng Y, Xu ZF, Xu B, Liu W, Wei YG, Li YH, Feng S, and Yang TY. Exploring cross-talk between oxidative damage and excitotoxicity and the effects of riluzole in the rat cortex after exposure to methylmercury. Neurotox Res 26: 40-51, 2014.
48. Denu JM and Tanner KG. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry 37: 5633-5642, 1998.
49. Di Domenico F, Cenini G, Sultana R, Perluigi M, Uberti D, Memo M, and Butterfield DA. Glutathionylation of the pro-apoptotic protein p53 in Alzheimer's disease brain: implications for AD pathogenesis (vol 34, pg 727, 2009). Neurochem Res 34: 1354-1354, 2009.
50. Dinoto L,DetureMA, and PurichDL. Structural insights into Alzheimer filament assembly pathways based on sitedirected mutagenesis and S-glutathionylation of three-repeat neuronal Tau protein. Microsc Res Tech 67: 156-163, 2005.
51. Diwakar L, Kenchappa RS, Annepu J, and Ravindranath V. Downregulation of glutaredoxin but not glutathione loss leads to mitochondrial dysfunction in female mice CNS: implications in excitotoxicity. Neurochem Int 51: 37-46, 2007.
52. Doka E, Pader I, Biro A, Johansson K, Cheng Q, Ballago K, Prigge JR, Pastor-Flores D, Dick TP, Schmidt EE, Arner ES, and Nagy P. A novel persulfide detection method reveals protein persulfide-and polysulfide-reducing functions of thioredoxin and glutathione systems. Sci Adv 2: e1500968, 2016.
53. Drechsel DA and Patel M. Respiration-dependent H2O2 removal in brain mitochondria via the thioredoxin/peroxiredoxin system. J Biol Chem 285: 27850-27858, 2010.
54. Dringen R. Metabolism and functions of glutathione in brain. Prog Neurobiol 62: 649-671, 2000.
55. Dringen R, Kussmaul L, Gutterer JM, Hirrlinger J, and Hamprecht B. The glutathione system of peroxide detoxification is less efficient in neurons than in astroglial cells. J Neurochem 72: 2523-2530, 1999.
56. Du Y, Zhang H, Lu J, and Holmgren A. Glutathione and glutaredoxin act as a backup of human thioredoxin reductase 1 to reduce thioredoxin 1 preventing cell death by aurothioglucose. J Biol Chem 287: 38210-38219, 2012.
57. Du Y, Zhang H, Zhang X, Lu J, and Holmgren A. Thioredoxin 1 is inactivated due to oxidation induced by peroxiredoxin under oxidative stress and reactivated by the glutaredoxin system. J Biol Chem 288: 32241-32247, 2013.
58. Duberley KE, Abramov AY, Chalasani A, Heales SJ, Rahman S, and Hargreaves IP. Human neuronal coenzyme Q10 deficiency results in global loss of mitochondrial respiratory chain activity, increased mitochondrial oxidative stress and reversal of ATP synthase activity: implications for pathogenesis and treatment. J Inherit Metab Dis 36: 63-73, 2013.
59. Fang JG, Nakamura T, Cho DH, Gu ZZ, and Lipton SA. S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease. Proc Natl Acad Sci U S A 104: 18742-18747, 2007.
60. Farina M, Aschner M, and Rocha JBT. Oxidative stress in MeHg-induced neurotoxicity. Toxicol Appl Pharmacol 256: 405-417, 2011.
61. Fernandes AP and Holmgren A. Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. Antioxid Redox Signal 6: 63-74, 2004.
62. Ferrer-Sueta G, Manta B, Botti H, Radi R, Trujillo M, and Denicola A. Factors affecting protein thiol reactivity and specificity in peroxide reduction. Chem Res Toxicol 24: 434-450, 2011.
63. Findlay VJ, Townsend DM, Morris TE, Fraser JP, He L, and Tew KD. A novel role for human sulfiredoxin in the reversal of glutathionylation. Cancer Res 66: 6800-6806, 2006.
64. Forsmark-Andree P, Persson B, Radi R, Dallner G, and Ernster L. Oxidative modification of nicotinamide nucleotide transhydrogenase in submitochondrial particles: effect of endogenous ubiquinol. Arch Biochem Biophys 336: 113-120, 1996.
65. Forstermann U, Boissel JP, and Kleinert H. Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J 12: 773-790, 1998.
66. Frei B, Kim MC, and Ames BN. Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proc Natl Acad Sci U S A 87: 4879-4883, 1990.
67. Gallogly MM, Shelton MD, Qanungo S, Pai HV, Starke DW, Hoppel CL, Lesnefsky EJ, and Mieyal JJ. Glutaredoxin regulates apoptosis in cardiomyocytes via NFkappaB targets Bcl-2 and Bcl-xL: implications for cardiac aging. Antioxid Redox Signal 12: 1339-1353, 2010.
68. Gan Y, Ji XM, HuXM, LuoYM, Zhang LL, Li PY, Liu XR, Yan F, Vosler P, Gao YQ, Stetler RA, and Chen J. Transgenic overexpression of peroxiredoxin-2 attenuates ischemic neuronal injury via suppression of a redox-sensitive prodeath signaling pathway. Antioxid Redox Signal 17: 719-732, 2012.
69. Garthwaite J. Concepts of neural nitric oxide-mediated transmission. Eur J Neurosci 27: 2783-2802, 2008.
70. Goedert M, Spillantini MG, Jakes R, Rutherford D, and Crowther RA. Multiple isoforms of human microtubuleassociated protein-Tau-sequences and localization in neurofibrillary tangles of Alzheimers-disease. Neuron 3: 519-526, 1989.
71. Gonzalez-Polo RA, Rodriguez-Martin A, Moran JM, Niso M, Soler G, and Fuentes JM. Paraquat-induced apoptotic cell death in cerebellar granule cells. Brain Res 1011: 170-176, 2004.
72. Gray JP, Heck DE, Mishin V, Smith PJS, Hong JY, Thiruchelvam M, Cory-Slechta DA, Laskin DL, and Laskin JD. Paraquat increases cyanide-insensitive respiration in murine lung epithelial cells by activating an NAD(P)H paraquat oxidoreductase-identification of the enzyme as thioredoxin reductase. J Biol Chem282: 7939-7949, 2007
73. Greetham D, Vickerstaff J, Shenton D, Perrone GG, Dawes IW, and Grant CM. Thioredoxins function as deglutathionylase enzymes in the yeast Saccharomyces cerevisiae. BMC Biochem 11: 3, 2010.
74. Gutscher M, Sobotta MC, Wabnitz GH, Ballikaya S, Meyer AJ, Samstag Y, and Dick TP. Proximity-based protein thiol oxidation by H2O2-scavenging peroxidases. J Biol Chem 284: 31532-31540, 2009.
75. Haendeler J, Hoffmann J, Tischler V, Berk BC, Zeiher AM, and Dimmeler S. Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. Nat Cell Biol 4: 743-749, 2002.
76. Halliwell B. Oxidative stress and neurodegeneration: where are we now? J Neurochem 97: 1634-1658, 2006.
77. Hanschmann EM, Lonn ME, Schutte LD, Funke M, Godoy JR, Eitner S, Hudemann C, and Lillig CH. Both thioredoxin 2 and glutaredoxin 2 contribute to the reduction of the mitochondrial 2-Cys peroxiredoxin Prx3. J Biol Chem 285: 40699-40705, 2010.
78. Hara MR, Agrawal N, Kim SF, Cascio MB, Fujimuro M, Ozeki Y, Takahashi M, Cheah JH, Tankou SK, Hester LD, Ferris CD, Hayward SD, Snyder SH, and Sawa A. Snitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat Cell Biol 7: 665-674, 2005.
79. Hashemy SI and Holmgren A. Regulation of the catalytic activity and structure of human thioredoxin 1 via oxidation and S-nitrosylation of cysteine residues. J Biol Chem 283: 21890-21898, 2008.
80. Haskew-Layton RE, Payappilly JB, Smirnova NA, Ma TC, Chan KK, Murphy TH, Guo H, Langley B, Sultana R, Butterfield DA, Santagata S, AlldredMJ, Gazaryan IG, Bell GW, Ginsberg SD, and Ratan RR. Controlled enzymatic production of astrocytic hydrogen peroxide protects neurons fromoxidative stress via an Nrf2-independent pathway. Proc Natl Acad Sci U S A 107: 17385-17390, 2010.
81. Hendriks WJ, Elson A, Harroch S, Pulido R, Stoker A, and den Hertog J. Protein tyrosine phosphatases in health and disease. FEBS J 280: 708-730, 2013.
82. Hill KE, McCollum GW, Boeglin ME, and Burk RF. Thioredoxin reductase activity is decreased by selenium deficiency. Biochem Biophys Res Commun 234: 293-295, 1997.
83. Holcik M and Korneluk RG. XIAP, the guardian angel. Nat Rev Mol Cell Biol 2: 550-556, 2001.
84. Holmgren A. Thioredoxin. Annu Rev Biochem 54: 237-271, 1985.
85. Holmgren A and Lu J. Thioredoxin and thioredoxin reductase: current research with special reference to human disease. Biochem Biophys Res Commun 396: 120-124, 2010.
86. Holmgren A and Sengupta R. The use of thiols by ribonucleotide reductase. Free Radic Biol Med 49: 1617-1628, 2010.
87. Hwang J, Suh HW, Jeon YH, Hwang E, Nguyen LT, Yeom J, Lee SG, Lee C, Kim KJ, Kang BS, Jeong JO, Oh TK, Choi I, Lee JO, and Kim MH. The structural basis for the negative regulation of thioredoxin by thioredoxininteracting protein. Nat Commun 5: 2958, 2014.
88. Hyson HC, Kieburtz K, Shoulson I, McDermott M, Ravina B, de Blieck EA, Cudkowicz ME, Ferrante RJ, Como P, Frank S, Zimmerman C, Ferrante K, Newhall K, Jennings D, Kelsey T, Walker F, Hunt V, Daigneault S, Goldstein M, Weber J, Watts A, Beal MF, Browne SE, and Metakis LJ. Safety and tolerability of high-dosage coenzyme Q10 in Huntington's disease and healthy subjects. Mov Disord 25: 1924-1928, 2010.
89. Ichinohe A, Kanaumi T, Takashima S, Enokido Y, Nagai Y, and Kimura H. Cystathionine beta-synthase is enriched in the brains of Down's patients. Biochem Biophys Res Commun 338: 1547-1550, 2005.
90. Jellinger KA. Basic mechanisms of neurodegeneration: a critical update. J Cell Mol Med 14: 457-487, 2010.
91. Johansson C, Lillig CH, and Holmgren A. Human mitochondrial glutaredoxin reduces S-glutathionylated proteins with high affinity accepting electrons from either glutathione or thioredoxin reductase. J Biol Chem 279: 7537-7543, 2004.
92. This reference has been deleted.
93. Johnson WM, Golczak M, Choe K, Currran PL, Gorelenkova Miller O, Yao C, Wang W, Lin J, Milkovic NM, Ray A, Ravindranath V, Zhu X, Wilson MA, Wilson-Delfosse AL, Chen SG, and Mieyal JJ. Regulation of DJ-1 by glutaredoxin 1 in vivo-implications for Parkinson's disease. Biochemistry, 55: 4519-4532, 2016.
94. Johnson WM, Yao C, Siedlak SL, Wang WZ, Zhu XW, Caldwell GA, Wilson-Delfosse AL, Mieyal JJ, and Chen SG. Glutaredoxin deficiency exacerbates neurodegeneration in C. elegans models of Parkinson's disease. Hum Mol Genet 24: 1322-1335, 2015.
95. Jones DP. Redefining oxidative stress. Antioxid Redox Signal 8: 1865-1879, 2006.
96. Ju Y, Wu L, and Yang G. Thioredoxin 1 regulation of protein S-desulfhydration. Biochem Biophys Rep 5: 27-34, 2016.
97. Kang Y, Viswanath V, Jha N, Qiao X, Mo JQ, and Andersen JK. Brain gamma-glutamyl cysteine synthetase (GCS) mRNA expression patterns correlate with regionalspecific enzyme activities and glutathione levels. J Neurosci Res 58: 436-441, 1999.
98. Kaur P, Aschner M, and Syversen T. Glutathione modulation influences methyl mercury induced neurotoxicity in primary cell cultures of neurons and astrocytes. Neurotoxicology 27: 492-500, 2006.
99. Kelleher ZT, Matsumoto A, Stamler JS, and Marshall HE. NOS2 regulation of NF-kappaB by S-nitrosylation of p65. J Biol Chem 282: 30667-30672, 2007.
100. Kemmerling U, Munoz P, Muller M, Sanchez G, Aylwin ML, Klann E, Carrasco MA, and Hidalgo C. Calcium release by ryanodine receptors mediates hydrogen peroxide-induced activation of ERK and CREB phosphorylation in N2a cells and hippocampal neurons. Cell Calcium 41: 491-502, 2007.
101. Kenchappa RS and Ravindranath V. Glutaredoxin is essential for maintenance of brain mitochondrial complex I: studies with MPTP. FASEB J 17: 717-719, 2003.
102. Kil IS and Park JW. Regulation of mitochondrial NADP(+)-dependent isocitrate dehydrogenase activity by glutathionylation. J Biol Chem 280: 10846-10854, 2005.
103. Kimura Y, Goto Y, and Kimura H. Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria. Antioxid Redox Signal 12: 1-13, 2010.
104. Krapfenbauer K, Engidawork E, Cairns N, Fountoulakis M, and Lubec G. Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Brain Res 967: 152-160, 2003.
105. Krishnan N, Fu C, Pappin DJ, and Tonks NK. H2SInduced sulfhydration of the phosphatase PTP1B and its role in the endoplasmic reticulum stress response. Sci Signal 4: ra86, 2011.
106. This reference has been deleted.
107. Kwong LK, Kamzalov S, Rebrin I, Bayne AC, Jana CK, Morris P, Forster MJ, and Sohal RS. Effects of coenzyme Q(10) administration on its tissue concentrations, mitochondrial oxidant generation, and oxidative stress in the rat. Free Radic Biol Med 33: 627-638, 2002.
108. Lakshmi BVS, Sudhakar M, and Prakash KS. Protective effect of selenium against aluminum chloride-induced Alzheimer's disease: behavioral and biochemical alterations in rats. Biol Trace Elem Res 165: 67-74, 2015.
109. Laurent TC, Moore EC, and Reichard P. Enzymatic synthesis of deoxyribonucleotides. Iv. Isolation and characterization of thioredoxin, the hydrogen donor from Escherichia coli B. J Biol Chem 239: 3436-3444, 1964.
110. Leak RK, Zhang LL, Luo YM, Li PY, Zhao HP, Liu XR, Ling F, Jia JP, Chen J, and Ji XM. Peroxiredoxin 2 battles poly(ADP-ribose) polymerase 1-and p53-dependent prodeath pathways after ischemic injury. Stroke 44: 1124-1134, 2013.
111. Lee BC, Dikiy A, Kim HY, and Gladyshev VN. Functions and evolution of selenoprotein methionine sulfoxide reductases. Biochim Biophys Acta 1790: 1471-1477, 2009.
112. Lee H, Yi JS, Lawan A, Min K, and Bennett AM. Mining the function of protein tyrosine phosphatases in health and disease. Semin Cell Dev Biol 37: 66-72, 2015.
113. Lee SR, Kwon KS, Kim SR, and Rhee SG. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J Biol Chem 273: 15366-15372, 1998.
114. Li F, Sonveaux P, Rabbani ZN, Liu SL, Yan B, Huang Q, Vujaskovic Z, Dewhirst MW, and Li CY. Regulation of HIF-1 alpha stability through S-nitrosylation. Mol Cell 26: 63-74, 2007.
115. Lin MT and Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443: 787-795, 2006.
116. Lipton SA, Choi YB, Takahashi H, Zhang DX, Li WZ, Godzik A, and Bankston LA. Cysteine regulation of protein function-as exemplified by NMDA-receptor modulation. Trends Neurosci 25: 474-480, 2002.
117. Ljubisavljevic S, Stojanovic I, Cvetkovic T, Vojinovic S, Stojanov D, Stojanovic D, Bojanic V, Stokanovic D, and Pavlovic D. Glutathione homeostasis disruption of erythrocytes, but not glutathione peroxidase activity change, is closely accompanied with neurological and radiological scoring of acute CNS inflammation. Neuroimmunomodulation 21: 13-20, 2014.
118. Lopert P, Day BJ, and Patel M. Thioredoxin reductase deficiency potentiates oxidative stress, mitochondrial dysfunction and cell death in dopaminergic cells. PLoS One 7: e50683, 2012.
119. Lopert P and Patel M. Nicotinamide nucleotide transhydrogenase (Nnt) links the substrate requirement in brain mitochondria for hydrogen peroxide removal to the thioredoxin/peroxiredoxin (Trx/Prx) system. J Biol Chem 289: 15611-15620, 2014.
120. Lovell MA, Xie C, Gabbita SP, and Markesbery WR. Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain. Free Radic Biol Med 28: 418-427, 2000.
121. Lu J and Holmgren A. Selenoproteins. J Biol Chem 284: 723-727, 2009.
122. Lu J and Holmgren A. The thioredoxin antioxidant system. Free Radic Biol Med 66: 75-87, 2014.
123. Lu J, Zhong L, Lonn ME, Burk RF, Hill KE, and Holmgren A. Penultimate selenocysteine residue replaced by cysteine in thioredoxin reductase from seleniumdeficient rat liver. FASEB J 23: 2394-2402, 2009.
124. Lundberg M, Johansson C, Chandra J, Enoksson M, Jacobsson G, Ljung J, Johansson M, and Holmgren A. Cloning and expression of a novel human glutaredoxin (Grx2) with mitochondrial and nuclear isoforms. J Biol Chem 276: 26269-26275, 2001.
125. Luthman M and Holmgren A. Rat liver thioredoxin and thioredoxin reductase: purification and characterization. Biochemistry 21: 6628-6633, 1982.
126. Madrigal JL, Olivenza R, Moro MA, Lizasoain I, Lorenzo P, Rodrigo J, and Leza JC. Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain. Neuropsychopharmacology 24: 420-429, 2001.
127. Martin JL. Thioredoxin-a fold for all reasons. Structure 3: 245-250, 1995.
128. Masaki C, Sharpley AL, Godlewska BR, Berrington A, Hashimoto T, Singh N, Vasudevan SR, Emir UE, Churchill GC, and Cowen PJ. Effects of the potential lithium-mimetic, ebselen, on brain neurochemistry: a magnetic resonance spectroscopy study at 7 tesla. Psychopharmacology 233: 1097-1104, 2016.
129. Mattson MP and Magnus T. Ageing and neuronal vulnerability. Nat Rev Neurosci 7: 278-294, 2006.
130. Maurya PK, Noto C, Rizzo LB, Rios AC, Nunes SOV, Barbosa DS, Sethi S, Zeni M, Mansur RB, Maes M, and Brietzke E. The role of oxidative and nitrosative stress in accelerated aging and major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 65: 133-144, 2016.
131. Mayer B, John M, and Bohme E. Purification of a Ca2+/ calmodulin-dependent nitric oxide synthase from porcine cerebellum. Cofactor-role of tetrahydrobiopterin. FEBS Lett 277: 215-219, 1990.
132. McCarthy S, Somayajulu M, Sikorska M, Borowy-Borowski H, and Pandey S. Paraquat induces oxidative stress and neuronal cell death; neuroprotection by watersoluble Coenzyme Q10. Toxicol Appl Pharmacol 201: 21-31, 2004.
133. Mieyal JJ, Gallogly MM, Qanungo S, Sabens EA, and Shelton MD. Molecular mechanisms and clinical implications of reversible protein S-glutathionylation. Antioxid Redox Signal 10: 1941-1988, 2008.
134. Mikami Y, Shibuya N, Kimura Y, Nagahara N, Ogasawara Y, and Kimura H. Thioredoxin and dihydrolipoic acid are required for 3-mercaptopyruvate sulfurtransferase to produce hydrogen sulfide. Biochem J 439: 479-485, 2011.
135. Mir S, Sen T, and Sen N. Cytokine-induced GAPDH sulfhydration affects PSD95 degradation and memory. Mol Cell 56: 786-795, 2014.
136. Mitchell DA and Marletta MA. Thioredoxin catalyzes the S-nitrosation of the caspase-3 active site cysteine. Nat Chem Biol 1: 154-158, 2005.
137. Mitsui A, Hamuro J, Nakamura H, Kondo N, Hirabayashi Y, Ishizaki-Koizumi S, Hirakawa T, Inoue T, and Yodoi J. Overexpression of human thioredoxin in transgenic mice controls oxidative stress and life span. Antioxid Redox Signal 4: 693-696, 2002.
138. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 417: 1-13, 2009.
139. Musik I, Kielczykowska M, and Kocot J. Oxidant balance in brain of rats receiving different compounds of selenium. Biometals 26: 763-771, 2013.
140. Mustafa AK, Gadalla MM, Sen N, Kim S, Mu WT, Gazi SK, Barrow RK, Yang GD, Wang R, and Snyder SH. H2S signals through protein S-sulfhydration. Sci Signal 2: ra72, 2009.
141. Mustafa AK, Kumar M, Selvakumar B, Ho GP, Ehmsen JT, Barrow RK, Amzel LM, and Snyder SH. Nitric oxide S-nitrosylates serine racemase, mediating feedback inhibition of D-serine formation. Proc Natl Acad Sci U S A 104: 2950-2955, 2007.
142. Nair PMG and Choi J. Characterization and transcriptional regulation of thioredoxin reductase 1 on exposure to oxidative stress inducing environmental pollutants in Chironomus riparius. Comp Biochem Physiol B Biochem Mol Biol 161: 134-139, 2012.
143. Nakajima H, Amano W, Fujita A, Fukuhara A, Azuma YT, Hata F, Inui T, and TakeuchiT.The active site cysteine of the proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase is essential in oxidative stress-induced aggregation and cell death. J Biol Chem 282: 26562-26564, 2007.
144. Newman SF, Sultana R, Perluigi M, Coccia R, Cai J, Pierce WM, Klein JB, Turner DM, and Butterfield DA. An increase in S-glutathionylated proteins in the Alzheimer's disease inferior parietal lobule, a proteomics approach. J Neurosci Res 85: 1506-1514, 2007.
145. Ni MW, Li X, Yin ZB, Sidoryk-Wegrzynowicz M, Jiang HY, Farina M, Rocha JBT, Syversen T, and Aschner M. Comparative study on the response of rat primary astrocytes and microglia to methylmercury toxicity. Glia 59: 810-820, 2011.
146. Nishitoh H, Matsuzawa A, Tobiume K, Saegusa K, Takeda K, Inoue K, Hori S, Kakizuka A, and Ichijo H. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev 16: 1345-1355, 2002.
147. Nishiyama A, Matsui M, Iwata S, Hirota K, Masutani H, Nakamura H, Takagi Y, Sono H, Gon Y, and Yodoi J. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 274: 21645-21650, 1999.
148. Olivera GC, Ren X, Vodnala SK, Lu J, Coppo L, Leepiyasakulchai C, Holmgren A, Kristensson K, and Rottenberg ME. Nitric oxide protects against infectioninduced neuroinflammation by preserving the stability of the blood-brain barrier. PLoS Pathog 12: e1005442, 2016.
149. Oslowski CM, Hara T, O'Sullivan-Murphy B, Kanekura K, Lu S,HaraM, Ishigaki S, ZhuLJ, HayashiE,Hui ST,Greiner D, Kaufman RJ, Bortell R, and Urano F. Thioredoxininteracting protein mediates ER stress-induced beta cell death through initiation of the inflammasome. CellMetab 16: 265-273, 2012.
150. Papadia S, Soriano FX, Leveille F, Martel MA, Dakin KA, Hansen HH, Kaindl A, Sifringer M, Fowler J, Stefovska V, McKenzie G, Craigon M, Corriveau R, Ghazal P, Horsburgh K, Yankner BA, Wyllie DJ, Ikonomidou C, and Hardingham GE. Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat Neurosci 11: 476-487, 2008.
151. Papp LV, Lu J, Holmgren A, and Khanna KK. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal 9: 775-806, 2007.
152. This reference has been deleted.
153. Pastore A, Tozzi G, Gaeta LM, Bertini E, Serafini V, Di Cesare S, Bonetto V, Casoni F, Carrozzo R, Federici G, and Piemonte F. Actin glutathionylation increases in fibroblasts of patients with Friedreich's ataxia-a potential role in the pathogenesis of the disease. J Biol Chem 278: 42588-42595, 2003.
154. Patra RC, Swarup D, and Dwivedi SK. Antioxidant effects of alpha tocopherol, ascorbic acid and L-methionine on lead induced oxidative stress to the liver, kidney and brain in rats. Toxicology 162: 81-88, 2001.
155. Peltoniemi MJ, Karala AR, Jurvansuu JK, Kinnula VL, and Ruddock LW. Insights into deglutathionylation reactions-different intermediates in the glutaredoxin and protein disulfide isomerase catalyzed reactions are defined by the gamma-linkage present in glutathione. J Biol Chem 281: 33107-33114, 2006.
156. Peng XX, Xu JQ, and Arner ESJ. Thiophosphate and selenite conversely modulate cell death induced by glutathione depletion or cisplatin: effects related to activity and Sec contents of thioredoxin reductase. Biochem J 447: 167-174, 2012.
157. Perry TL, Yong VW, Bergeron C, Hansen S, and Jones K. Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease. Ann Neurol 21: 331-336, 1987.
158. Peskin AV, Pace PE, Behring JB, Paton LN, Soethoudt M, Bachschmid MM, and Winterbourn CC. Glutathionylation of the active site cysteines of peroxiredoxin 2 and recycling by glutaredoxin. J Biol Chem 291: 3053-3062, 2016.
159. Peters GH, Frimurer TM, and Olsen OH. Electrostatic evaluation of the signature motif (H/V)CX5R(S/T) in protein-tyrosine phosphatases. Biochemistry 37: 5383-5393, 1998.
160. Pirazzini M, Azarnia Tehran D, Zanetti G, Megighian A, Scorzeto M, Fillo S, Shone CC, Binz T, Rossetto O, Lista F, and Montecucco C. Thioredoxin and its reductase are present on synaptic vesicles, and their inhibition prevents the paralysis induced by botulinum neurotoxins. Cell Rep 8: 1870-1878, 2014.
161. Pollock JS, Forstermann U, Mitchell JA, Warner TD, Schmidt HH, Nakane M, and Murad F. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci U S A 88: 10480-10484, 1991.
162. Radyuk SN, Sohal RS, and Orr WC. Thioredoxin peroxidases can foster cytoprotection or cell death in response to different stressors: over-and under-expression of thioredoxin peroxidase in Drosophila cells. Biochem J 371: 743-752, 2003.
163. Ramassamy C, Averill D, Beffert U, Theroux L, Lussier-Cacan S, Cohn JS, Christen Y, Schoofs A, Davignon J, and Poirier J. Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain. Neurobiol Dis 7: 23-37, 2000.
164. Ranjbar A, Pasalar P, Sedighi A, and Abdollahi M. Induction of oxidative stress in paraquat formulating workers. Toxicol Lett 131: 191-194, 2002.
165. Reilly C. Selenium in Food and Health. New York: Springer, 2006, xvi, p. 206.
166. Rodrigues J, Branco V, Lu J, Holmgren A, and Carvalho C. Toxicological effects of thiomersal and ethylmercury: inhibition of the thioredoxin system and NADP(+)-dependent dehydrogenases of the pentose phosphate pathway. Toxicol Appl Pharmacol 286: 216-223, 2015.
167. Roede JR, Hansen JM, Go YM, and Jones DP. Maneb and paraquat-mediated neurotoxicity: involvement of peroxiredoxin/ thioredoxin system. Toxicol Sci 121: 368-375, 2011.
168. Romagnoli A, Oradei A, Destito C, Iacocagni A, Marin AW, and Littarru GP. Protective role in vivo of coenzyme Q10 during reperfusion of ischemic limbs. Mol Aspects Med 15 Suppl: s177-s185, 1994.
169. Rooney JPK. The role of thiols, dithiols, nutritional factors and interacting ligands in the toxicology of mercury. Toxicology 234: 145-156, 2007.
170. Sandalova T, Zhong L, Lindqvist Y, Holmgren A, and Schneider G. Three-dimensional structure of a mammalian thioredoxin reductase: implications for mechanism and evolution of a selenocysteine-dependent enzyme. Proc Natl Acad Sci U S A 98: 9533-9538, 2001.
171. Santa Maria C and Machado A. Effects of development and ageing on pulmonary NADPH-cytochrome c reductase, glutathione peroxidase, glutathione reductase and thioredoxin reductase activities in male and female rats. Mech Ageing Dev 37: 183-195, 1986.
172. Sarafian TA, Verity MA, Vinters HV, Shih CCY, Shi LR, Ji XD, Dong LP, and Shau HY. Differential expression of peroxiredoxin subtypes in human brain cell types. J Neurosci Res 56: 206-212, 1999.
173. Sarkar S, Korolchuk VI, Renna M, Imarisio S, Fleming A, Williams A, Garcia-Arencibia M, Rose C, Luo S,Underwood BR, Kroemer G, O'Kane CJ, and Rubinsztein DC. Complex inhibitory effects of nitric oxide on autophagy. Mol Cell 43: 19-32, 2011.
174. Schilling G, Coonfield ML, Ross CA, and Borchelt DR. Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington's disease transgenic mouse model. Neurosci Lett 315: 149-153, 2001.
175. Schulz JB, Lindenau J, Seyfried J, and Dichgans J. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 267: 4904-4911, 2000.
176. Sen N, Paul BD, Gadalla MM, Mustafa AK, Sen T, Xu R, Kim S, and Snyder SH. Hydrogen sulfide-linked sulfhydration of NF-kappaB mediates its antiapoptotic actions. Mol Cell 45: 13-24, 2012.
177. Shimizu K, Matsubara K, Ohtaki K, Fujimaru S, Saito O, and Shiono H. Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats. Brain Res 976: 243-252, 2003.
178. Sian J, Dexter DT, Lees AJ, Daniel S, Jenner P, and Marsden CD. Glutathione-related enzymes in brain in Parkinson's disease. Ann Neurol 36: 356-361, 1994.
179. Silva-Adaya D, Gonsebatt ME, and Guevara J. Thioredoxin system regulation in the central nervous system: experimental models and clinical evidence. Oxid Med Cell Longev 2014: 590808, 2014.
180. Sinet PM, Heikkila RE, and Cohen G. Hydrogen peroxide production by rat brain in vivo. J Neurochem 34: 1421-1428, 1980.
181. Somayajulu M, McCarthy S, Hung M, Sikorska M, Borowy-Borowski H, and Pandey S. Role of mitochondria in neuronal cell death induced by oxidative stress; neuroprotection by coenzyme Q(10). Neurobiol Dis 18: 618-627, 2005.
182. Sparaco M, Gaeta LM, Tozzi G, Bertini E, Pastore A, Simonati A, Santorelli FM, and Piemonte F. Protein glutathionylation in human central nervous system: potential role in redox regulation of neuronal defense against free radicals. J Neurosci Res 83: 256-263, 2006.
183. Sreekala S and Indira M. Impact of co administration of selenium and quinolinic acid in the rat's brain. Brain Res 1281: 101-107, 2009.
184. Starkov AA, Andreyev AY, Zhang SF, Starkova NN, Korneeva M, Syromyatnikov M, and Popov VN. Scavenging of H2O 2 by mouse brain mitochondria. J Bioenerg Biomembr 46: 471-477, 2014.
185. Stone JR and Yang S. Hydrogen peroxide: a signaling messenger. Antioxid Redox Signal 8: 243-270, 2006.
186. Sun N, Hao JR, Li XY, Yin XH, Zong YY, Zhang GY, and Gao C. GluR6-FasL-Trx2 mediates denitrosylation and activation of procaspase-3 in cerebral ischemia/reperfusion in rats. Cell Death Dis 4: e771, 2013.
187. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, and Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270: 296-299, 1995.
188. Takizawa M, Komori K, Tampo Y, and Yonaha M. Paraquat-induced oxidative stress and dysfunction of cellular redox systems including antioxidative defense enzymes glutathione peroxidase and thioredoxin reductase. Toxicol In Vitro 21: 355-363, 2007.
189. Tampo Y, Tsukamoto M, and Yonaha M. Superoxide production from paraquat evoked by exogenous NADPH in pulmonary endothelial cells. Free Radic Biol Med 27: 588-595, 1999.
190. Taylor ER, Hurrell F, Shannon RJ, Lin TK, Hirst J, and Murphy MP. Reversible glutathionylation of complex I increases mitochondrial superoxide formation. J Biol Chem 278: 19603-19610, 2003.
191. Tenneti L, D'Emilia DM, and Lipton SA. Suppression of neuronal apoptosis by S-nitrosylation of caspases. Neurosci Lett 236: 139-142, 1997.
192. Tomasetti M, Alleva R, Borghi B, and Collins AR. In vivo supplementation with coenzyme Q10 enhances the recovery of human lymphocytes from oxidative DNA damage. FASEB J 15: 1425-1427, 2001.
193. Tong J, Fitzmaurice PS, Moszczynska A, Mattina K, Ang L-C, Boileau I, Furukawa Y, Sailasuta N, and Kish SJ. Do glutathione levels decline in aging human brain? Free Radic Biol Med 93: 110-117, 2016.
194. Tonks NK, Yang Q, and Guida P, Jr. Structure, regulation, and function of protein tyrosine phosphatases. Cold Spring Harbor Symp Quant Biol 56: 265-273, 1991.
195. Tretter L, Sipos I, and Adam-Vizi V. Initiation of neuronal damage by complex I deficiency and oxidative stress in Parkinson's disease. Neurochem Res 29: 569-577, 2004.
196. Tsang AH, Lee YI, Ko HS, Savitt JM, Pletnikova O, Troncoso JC, Dawson VL, Dawson TM, and Chung KK. S-nitrosylation of XIAP compromises neuronal survival in Parkinson's disease. Proc Natl Acad Sci U S A 106: 4900-4905, 2009.
197. Tsuda M, Ootaka R, Ohkura C, Kishita Y, Seong KH, Matsuo T, and Aigaki T. Loss of Trx-2 enhances oxidative stress-dependent phenotypes in Drosophila. FEBS Lett 584: 3398-3401, 2010.
198. Tsukamoto M, Tampo Y, Sawada M, and Yonaha M. Paraquat-induced oxidative stress and dysfunction of the glutathione redox cycle in pulmonary microvascular endothelial cells. Toxicol Appl Pharmacol 178: 82-92, 2002.
199. Uehara T, Nakamura T, Yao DD, Shi ZQ, Gu ZZ, Ma YL, Masliah E, Nomura Y, and Lipton SA. S-Nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 441: 513-517, 2006.
200. Um HC, Jang JH, Kim DH, Lee C, and Surh YJ. Nitric oxide activates Nrf2 through S-nitrosylation of Keap1 in PC12 cells. Nitric Oxide Biol Chem 25: 161-168, 2011.
201. Vahter M, Mottet NK, Friberg L, Lind B, Shen DD, and Burbacher T. Speciation of mercury in the primate blood and brain following long-term exposure to methyl mercury. Toxicol Appl Pharmacol 124: 221-229, 1994.
202. Vandiver MS, Paul BD, Xu RS, Karuppagounder S, Rao F, Snowman AM, Ko HS, Il Lee Y, Dawson VL, Dawson TM, Sen N, and Snyder SH. Sulfhydration mediates neuroprotective actions of parkin. Nat Commun 4: 1626, 2013.
203. Velu CS, Niture SK, Doneanu CE, Pattabiraman N, and Srivenugopal KS. Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNAbinding domain during oxidative stress. Biochemistry 46: 7765-7780, 2007.
204. Waly M, Power-Charnitsky VA, Hodgson N, Sharma A, Audhya T, Zhang Y, and Deth R. Alternatively spliced methionine synthase in SH-SY5Y neuroblastoma cells: cobalamin and GSH dependence and inhibitory effects of neurotoxic metals and thimerosal. Oxid Med Cell Longev 2016: 6143753, 2016.
205. Wedmann R, Onderka C, Wei S, Szijarto IA, Miljkovic JL, Mitrovic A, Lange M, Savitsky S, Yadav PK, Torregrossa R, Harrer EG, Harrer T, Ishii I, Gollasch M, Wood ME, Galardon E, Xian M, Whiteman M, Banerjee R, and Filipovic MR. Improved tag-switch method reveals that thioredoxin acts as depersulfidase and controls the intracellular levels of protein persulfidation. Chem Sci 7: 3414-3426, 2016.
206. Weichsel A, Brailey JL, and Montfort WR. Buried Snitrosocysteine revealed in crystal structures of human thioredoxin. Biochemistry 46: 1219-1227, 2007.
207. Winterbourn CC and Hampton MB. Thiol chemistry and specificity in redox signaling. Free Radic Biol Med 45: 549-561, 2008.
208. Woo HA, Yim SH, Shin DH, Kang D, Yu DY, and Rhee SG. Inactivation of peroxiredoxin I by phosphorylation allows localized H(2)O(2) accumulation for cell signaling. Cell 140: 517-528, 2010.
209. Wu C, Liu T, Chen W, Oka S, Fu C, Jain MR, Parrott AM, Baykal AT, Sadoshima J, and Li H. Redox regulatory mechanism of transnitrosylation by thioredoxin. Mol Cell Proteomics: MCP 9: 2262-2275, 2010.
210. Wu C, Parrott AM, Liu T, Jain MR, Yang Y, Sadoshima J, and Li H. Distinction of thioredoxin transnitrosylation and denitrosylation target proteins by the ICAT quantitative approach. J Proteomics 74: 2498-2509, 2011.
211. Xia L, Nordman T, Olsson JM, Damdimopoulos A, Bjorkhem-Bergman L, Nalvarte I, Eriksson LC, Arner ES, Spyrou G, and Bjornstedt M. The mammalian cytosolic selenoenzyme thioredoxin reductase reduces ubiquinone. A novel mechanism for defense against oxidative stress. J Biol Chem 278: 2141-2146, 2003.
212. Xie ZZ, Shi MM, Xie L, Wu ZY, Li G, Hua F, and Bian JS. Sulfhydration of p66Shc at cysteine59 mediates the antioxidant effect of hydrogen sulfide. Antioxid Redox Signal 21: 2531-2542, 2014.
213. Xu C, Bailly-Maitre B, and Reed JC. Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest 115: 2656-2664, 2005.
214. Yamaguchi T, Sano K, Takakura K, Saito I, Shinohara Y, Asano T, Yasuhara H, and Grp ES. Ebselen in acute ischemic stroke-a placebo-controlled, double-blind clinical trial. Stroke 29: 12-17, 1998.
215. Yang G, Zhao K, Ju Y, Mani S, Cao Q, Puukila S, Khaper N, Wu L, and Wang R. Hydrogen sulfide protects against cellular senescence via S-sulfhydration ofKeap1 and activation of Nrf2. Antioxid Redox Signal 18: 1906-1919, 2013.
216. Yang W, Tiffany-Castiglioni E, Lee MY, and Son IH. Paraquat induces cyclooxygenase-2 (COX-2) implicated toxicity in human neuroblastoma SH-SY5Y cells. Toxicol Lett 199: 239-246, 2010.
217. Yao D, Gu Z, Nakamura T, Shi ZQ, Ma Y, Gaston B, Palmer LA, Rockenstein EM, Zhang Z, Masliah E, Uehara T, and Lipton SA. Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc Natl Acad Sci U S A 101: 10810-10814, 2004.
218. Yasinska IM and Sumbayev VV. S-nitrosation of Cys-800 of HIF-1alpha protein activates its interaction with p300 and stimulates its transcriptional activity. FEBS Lett 549: 105-109, 2003.
219. Yeh ST, Guo HR, Su YS, Lin HJ, Hou CC, Chen HM, Chang MC, and Wang YJ. Protective effects of Nacetylcysteine treatment post acute paraquat intoxication in rats and in human lung epithelial cells. Toxicology 223: 181-190, 2006.
220. Zemolin APP, Meinerz DF, de Paula MT, Mariano DOC, Rocha JBT, Pereira AB, Posser T, and Franco JL. Evidences for a role of glutathione peroxidase 4 (GPx4) in methylmercury induced neurotoxicity in vivo. Toxicology 302: 60-67, 2012.
221. Zhang H, Du Y, Zhang X, Lu J, and Holmgren A. Glutaredoxin 2 reduces both thioredoxin 2 and thioredoxin 1 and protects cells from apoptosis induced by auranofin and 4-hydroxynonenal. Antioxid Redox Signal 21: 669-681, 2014.
222. Zhang R, Al-Lamki R, Bai L, Streb JW, Miano JM, Bradley J, and Min W. Thioredoxin-2 inhibits mitochondria-located ASK1-mediated apoptosis in a JNK-independent manner. Circ Res 94: 1483-1491, 2004.
223. Zhang Y, Zhou Y, Schweizer U, Savaskan NE, Hua D, Kipnis J, Hatfield DL, and Gladyshev VN. Comparative analysis of selenocysteine machinery and selenoproteome gene expression in mouse brain identifies neurons as key functional sites of selenium in mammals. J Biol Chem 283: 2427-2438, 2008.
224. Zhong L and Holmgren A. Essential role of selenium in the catalytic activities of mammalian thioredoxin reductase revealed by characterization of recombinant enzymes with selenocysteine mutations. J Biol Chem 275: 18121-18128, 2000.